Ledger.Open graph →
SEC Form D · Amendment · filed November 20, 2014

EIGER BIOPHARMACEUTICALS INC

Offering
$7.3M
Sold
$7.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Santa Clara, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

David Cory · Santa Clara, CAExec · DirectorJeffrey Glenn · Santa Clara, CADirectorEd Engleman · Santa Clara, CADirectorNina Kjellson · Santa Clara, CADirectorSridhar Bearelly · New York, NYExec · DirectorJacob Freifeld · Palo Alto, CADirectorDavid Deutsch · New York, NYDirectorTracy Overath · Austin, TXDirectorStuart Griffiths · Grand Cayman, Cayman IslandsExec · DirectorJason Vickers · Grand Cayman, Cayman IslandsDirectorJesper Poulsen · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗